Back to results
US 2013/0210718 A1Published application
Biomarkers for Cardiodiabetes
AssigneeIKFE Institut fur Klinische Forschung und Entwicklung GMBH
InventorsAndreas PFUETZNER, Thomas FORST
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for determining cardiodiabetes status in a subject. The invention also provides compositions and methods for treating a subject experiencing cardiodiabetes.
Claims22
A composition comprising a solid support comprising:
- (a) a capture binding ligand selective for adiponectin,
- (b) a capture binding ligand selective for hsCRP, and
- (c) a capture binding ligand selective for intact proinsulin.
A method of treating cardiodiabetes in a subject comprising
- (a) measuring the concentration of a biomarker panel in a sample from the subject, the biomarker panel consisting of adiponectin, hsCRP and intact proinsulin;
- and
- (b) effecting a therapy with respect to the subject.
Dependencies are inferred from the claim text.